Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Amy Franke"'
Autor:
Katherine Fuh, Kathleen Moore, Thais Baert, Thomas Herzog, David Cibula, Joyce Liu, Laurianne Eberst, Sharon Lewin, Angeles Alvarez Secord, Jalid Sehouli, Tashanna Myers, Aristotelis Bamias, BJ Rimel, Nicoletta Colombo, Amy Franke, Dipti Shoop, Ugo De Giorgi, Joanna Pikiel, Rebecca Bowen, Antonio Gonzalez-Martin
Publikováno v:
E-Posters (Trials In Progress).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9644baa5e64430d7017f9af6687bdd2b
https://doi.org/10.1136/ijgc-2022-igcs.532
https://doi.org/10.1136/ijgc-2022-igcs.532
Autor:
Balaji Venugopal, Ramesh Boinpally, Lee S. Rosen, Cindy L. O'Bryant, Jeffry Evans, Amy Franke, Ramesh K. Ramanathan, Paul Haluska, Suresh Ramalingam, S. Gail Eckhardt, Chandra P. Belani, Karsten Witt, Stephen Leong
Publikováno v:
Cancer Chemotherapy and Pharmacology. 69:605-612
To compare the pharmacokinetic (PK) parameters of a single dose of erlotinib in cancer patients with moderate hepatic impairment (MHI) to those of cancer patients with adequate hepatic function (AHF).Cancer patients with either AHF or MHI were treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c6480069ab7e58009698de2d0914d2
https://doi.org/10.1007/s00280-011-1733-6
https://doi.org/10.1007/s00280-011-1733-6
Autor:
Serina King, Avery Spitz, Ramesh Boinpally, Roberto Pili, Mario A. Eisenberger, Amy Franke, Christopher Sweeney, Michael A. Carducci, Jennifer M. Porter, Lee P. Resta
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose To find the maximum tolerated dose (MTD) of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors. Methods This was a Phase I study using cohort dose escalation of OSI-461 dosed orally twice daily in combination with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79f683f7bdcef003a51ff04c5617448d
https://pubmed.ncbi.nlm.nih.gov/20445979
https://pubmed.ncbi.nlm.nih.gov/20445979